NEW YORK, March 8 – IBM’s investment in MDS Proteomics totaled $10 million, parent company MDS of Toronto disclosed Thursday.

In January, IBM made an equity investment in MDS Proteomics as part of a strategic collaboration that also included an agreement to jointly establish a publicly available web-based protein database. At the time of the deal neither party disclosed the size of the investment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.